Anagenesis Biotechnologies:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Anagenesis Biotechnologies - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C12350
◆発行会社(調査会社):GlobalData
◆発行日:2018年12月
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Anagenesis Biotechnologies is a pharmaceutical solutions provider that offers treatment for muscle degenerative diseases. The company provides cell therapy genetics and pharmacological drugs for genetic and age related diseases. It also carries out cell-based technologies to provide solutions for varied cell type and research. Anagenesis Biotechnologies technology helps in generating paraxial mesoderm multipotent cells and differentiated muscle cells through recapitulation of every step in the embryonic and foetal myogenesis in vitro. The company also funds for developing applications in muscular dystrophies, myotonic disorders, spinal muscular atrophies, metabolic diseases of the muscle and other myopathies. Anagenesis Biotechnologies is headquartered in Strasbourg, France.

Anagenesis Biotechnologies – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Anagenesis Biotechnologies, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Anagenesis Biotechnologies, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Anagenesis Biotechnologies, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Anagenesis Biotechnologies, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Anagenesis Biotechnologies, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Anagenesis Biotechnologies, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Anagenesis Biotech Raises Funds through Venture Financing 10
Anagenesis Biotech Raises Funds through Venture Financing Round 11
Partnerships 12
Anagenesis Biotechnologies Enters into Research Agreement with Boehringer Ingelheim 12
Licensing Agreements 13
CRISPR Therapeutics Enters into Licensing Agreement with Anagenesis Biotechnologies 13
Anagenesis Biotech Enters into Licensing Agreement with Inserm Transfert and AFM 14
Anagenesis Biotechnologies – Key Competitors 15
Anagenesis Biotechnologies – Key Employees 16
Anagenesis Biotechnologies – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
Anagenesis Biotechnologies, Pharmaceuticals & Healthcare, Key Facts 2
Anagenesis Biotechnologies, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Anagenesis Biotechnologies, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Anagenesis Biotechnologies, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Anagenesis Biotechnologies, Deals By Therapy Area, 2012 to YTD 2018 8
Anagenesis Biotechnologies, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Anagenesis Biotech Raises Funds through Venture Financing 10
Anagenesis Biotech Raises Funds through Venture Financing Round 11
Anagenesis Biotechnologies Enters into Research Agreement with Boehringer Ingelheim 12
CRISPR Therapeutics Enters into Licensing Agreement with Anagenesis Biotechnologies 13
Anagenesis Biotech Enters into Licensing Agreement with Inserm Transfert and AFM 14
Anagenesis Biotechnologies, Key Competitors 15
Anagenesis Biotechnologies, Key Employees 16
Anagenesis Biotechnologies, Other Locations 17

List of Figures
Anagenesis Biotechnologies, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Anagenesis Biotechnologies, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Anagenesis Biotechnologies, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Anagenesis Biotechnologies, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Anagenesis Biotechnologies, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Anagenesis Biotechnologies, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Anagenesis Biotechnologies, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Anagenesis Biotechnologies, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Anagenesis Biotechnologies:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Staples, Inc.:企業の戦略・SWOT・財務分析
    Staples, Inc. - Strategy, SWOT and Corporate Finance Report Summary Staples, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Trust International Insurance Co. P.L.C.:企業の戦略・SWOT・財務分析
    Trust International Insurance Co. P.L.C. - Strategy, SWOT and Corporate Finance Report Summary Trust International Insurance Co. P.L.C. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • International Fibres Group Ltd:企業の戦略的SWOT分析
    International Fibres Group Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • Juvenile Diabetes Research Foundation:製薬・医療:M&Aディール及び事業提携情報
    Summary Juvenile Diabetes Research Foundation (JDRF) is a research organization that offers funding services for type 1 diabetes. The organization conducts clinical trials for curing, preventing and treating for type 1 diabetes and its complications; and researching new drugs for patients to manage …
  • WAVE Life Sciences Ltd (WVE):企業の財務・戦略的SWOT分析
    Summary Wave Life Sciences Ltd (Wave Life Sciences) formerly WAVE Life Sciences Pte Ltd, discovers, develops and commercializes medicines for genetic diseases. The company's pipeline comprises an mRNA transcript candidates: WVE-120101 and WVE-120102 for Huntington's disease; ATXN3 gene candidate for …
  • Vinnolit GmbH & Co KG:企業の戦略的SWOT分析
    Vinnolit GmbH & Co KG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Titan Machinery Inc. (TITN):企業の財務・戦略的SWOT分析
    Titan Machinery Inc. (TITN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Apollo Endosurgery Inc (APEN):医療機器:M&Aディール及び事業提携情報
    Summary Apollo Endosurgery Inc (Apollo Endo), formerly Lpath Inc, is a medical technology company that designs, develops and commercializes medical devices used for the treatment of obesity. The company’s product portfolio comprises endo-bariatric products such as Orbera Intragastric Balloon System …
  • J.Crew Group, Inc.:企業の戦略・SWOT・財務情報
    J.Crew Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary J.Crew Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • SiteOne Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary SiteOne Therapeutics Inc (SiteOne) is a biopharmaceutical company that develops novel non-opioid pain therapeutics for the treatment of acute and chronic pain. The company’s lead therapeutic candidates include ST-2427 Intravenous, for post-operative pain; ST-SubQ Subcutaneous and ST-Oral, fo …
  • PT Tempo Scan Pacific Tbk (TSPC):企業の財務・戦略的SWOT分析
    PT Tempo Scan Pacific Tbk (TSPC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • CES Energy Solutions Corp (CEU):企業の財務・戦略的SWOT分析
    CES Energy Solutions Corp (CEU) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Cosmo Pharmaceuticals NV (COPN):企業の財務・戦略的SWOT分析
    Summary Cosmo Pharmaceuticals NV (Cosmo) is a pharmaceutical company that develops drugs for the treatment of gastro-intestinal diseases. The company develops its pharmaceutical products based on its multi matrix technology. Its proprietary clinical development pipeline intended for the treatment of …
  • Beacon Industries Inc.:企業の戦略・SWOT・財務情報
    Beacon Industries Inc. - Strategy, SWOT and Corporate Finance Report Summary Beacon Industries Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Dataprep Holdings Bhd (DATAPRP):企業の財務・戦略的SWOT分析
    Dataprep Holdings Bhd (DATAPRP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Generex Biotechnology Corp (GNBT):企業の財務・戦略的SWOT分析
    Generex Biotechnology Corp (GNBT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Hyduke Energy Services Inc:企業の戦略的SWOT分析
    Hyduke Energy Services Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Genedata AG-製薬・医療分野:企業M&A・提携分析
    Summary Genedata AG (Genedata) is a healthcare technology company that transforms data into software solutions. The company delivers enterprise solutions for data analytics that streamline research and development workflows and improve research productivity. Its products include genedata biologics, …
  • Nippon Suisan Kaisha, Ltd.:企業の戦略・SWOT・財務情報
    Nippon Suisan Kaisha, Ltd. - Strategy, SWOT and Corporate Finance Report Summary Nippon Suisan Kaisha, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Breko GmbH:企業の戦略・SWOT・財務情報
    Breko GmbH - Strategy, SWOT and Corporate Finance Report Summary Breko GmbH - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆